Envestnet Asset Management
GNMK

Envestnet Asset Management’s GenMark Diagnostics, Inc GNMK Stock Holding History

Envestnet Asset Management’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-25,813
Closed -$377K – 3608
2020
Q4 		$377K Buy
25,813
+1,480
+6% +$19.6K ﹤0.01% 2801
2020
Q3 		$346K Sell
24,333
-8,114
-25% -$124K ﹤0.01% 2675
2020
Q2 		$477K Sell
32,447
-64,681
-67% -$657K ﹤0.01% 2455
2020
Q1 		$400K Buy
97,128
+31,442
+48% +$147K ﹤0.01% 2405
2019
Q4 		$316K Buy
65,686
+6,798
+12% +$37.5K ﹤0.01% 2705
2019
Q3 		$357K Buy
58,888
+3,287
+6% +$20.5K ﹤0.01% 2560
2019
Q2 		$361K Buy
+55,601
New +$392K ﹤0.01% 2552

Other funds holding GNMK

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Envestnet Asset Management's GNMK Position: Q1 2021 in Review

Envestnet Asset Management sold out of GenMark Diagnostics, Inc (GNMK) in Q1 2021, closing a stake of 25,813 shares — an estimated $377K sold.

Envestnet Asset Management first reported a position in GNMK in Q2 2019 and held it in 7 quarters. The position peaked at $477K in Q2 2020. 164 funds tracked by Wall St. Rank hold GNMK as of Q1 2021.

  • Envestnet Asset Management reported no remaining GenMark Diagnostics, Inc position as of Q1 2021 after selling out during the quarter.
  • Envestnet Asset Management sold 25,813 GenMark Diagnostics, Inc shares in Q1 2021, an estimated $377K.
  • Envestnet Asset Management first reported a position in GenMark Diagnostics, Inc in Q2 2019 and held it in 7 quarters.
  • Envestnet Asset Management's GenMark Diagnostics, Inc position peaked at $477K in Q2 2020.
  • 164 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q1 2021.

Based on Envestnet Asset Management's 13F filing for Q1 2021, filed 4 May 2021.